Results 261 to 270 of about 290,432 (308)

Programmed cell-death-1-ligand-1 inhibitors/programmed cell-death-1-receptor antagonists

Reactions Weekly, 2020
openaire   +1 more source

Programmed-cell-death-1-receptor-antagonists /rituximab

Reactions Weekly, 2022
openaire   +1 more source

Lenvatinib/programmed cell death-1 receptor antagonists

Reactions Weekly, 2022
openaire   +1 more source

Programmed cell death-1 receptor antagonists

Reactions Weekly, 2020
openaire   +1 more source

Antineoplastics/programmed-cell-death-1-receptor-antagonists

Reactions Weekly, 2023
openaire   +1 more source

Catequentinib/programmed-cell-death-1-receptor-antagonists

Reactions Weekly, 2023
openaire   +1 more source

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Cancer Control, 2022
Bo Hao, Qing Geng
exaly  

Antineoplastics/programmed-cell-death-1-receptor-antagonists

Reactions Weekly, 2022
openaire   +1 more source

Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti‐CD19‐chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B‐cell lymphoma and high tumor burden

Hematological Oncology, 2023
Juan Mu, Qing Li, Jia Wang
exaly  

Programmed-cell-death-1-receptor-antagonists/rivoceranib

Reactions Weekly, 2020
openaire   +1 more source